PORT MORESBY - No funds should be awarded to these people (Niugini BioMed), no drugs should be procured, and no patients should be enrolled until their protocols have been scrutinised and vetted.
This should be done by the PNG Medical Research Advisory Committee and the PNG Institute of Medical Research.
These organisations have an established track record in conducting clinical trials, including compliance with international Good Clinical Practice (GCP) protocols.
Right now PNG has other important priorities in respect to Covid-19 that need funding.
These include prevention and containment of transmission, increased testing and exploring other options for diagnostics (for example, antigen tests).
Papua New Guinea must also secure vaccines should an appropriate candidate become available, and we must formulate a strategy for vaccination roll-out, including ongoing surveillance.